These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 3282480

  • 21. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [Abstract] [Full Text] [Related]

  • 22. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
    Nagy LM, Krystal JH, Woods SW, Charney DS.
    Arch Gen Psychiatry; 1989 Nov; 46(11):993-9. PubMed ID: 2818144
    [Abstract] [Full Text] [Related]

  • 23. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC, Swinson RP, Kuch K, Lewis CP.
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [Abstract] [Full Text] [Related]

  • 24. Treatment of panic disorder and agoraphobia with clonazepam.
    Spier SA, Tesar GE, Rosenbaum JF, Woods SW.
    J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
    [Abstract] [Full Text] [Related]

  • 25. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    Tesar GE, Rosenbaum JF, Pollack MH, Herman JB, Sachs GS, Mahoney EM, Cohen LS, McNamara M, Goldstein S.
    J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
    [Abstract] [Full Text] [Related]

  • 26. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S, Grunhaus L, Gladic D, O'Ryan F, Cohen L, Codner S.
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [Abstract] [Full Text] [Related]

  • 27. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA, Argyle N, Klerman GL.
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [Abstract] [Full Text] [Related]

  • 28. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 29. Reduction in hypochondriasis with treatment of panic disorder.
    Noyes R, Reich J, Clancy J, O'Gorman TW.
    Br J Psychiatry; 1986 Nov; 149():631-5. PubMed ID: 3814956
    [Abstract] [Full Text] [Related]

  • 30. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 31. Placebo response in panic disorder.
    Coryell W, Noyes R.
    Am J Psychiatry; 1988 Sep; 145(9):1138-40. PubMed ID: 3046384
    [Abstract] [Full Text] [Related]

  • 32. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M, Marks IM, Kiliç C, Swinson RP, Noshirvani H, Kuch K, O'Sullivan G.
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [Abstract] [Full Text] [Related]

  • 33. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 34. Three cases of panic disorder with agoraphobia in children.
    Ballenger JC, Carek DJ, Steele JJ, Cornish-McTighe D.
    Am J Psychiatry; 1989 Jul; 146(7):922-4. PubMed ID: 2742019
    [Abstract] [Full Text] [Related]

  • 35. Factors in the panic-agoraphobia transition.
    Katerndahl DA.
    J Am Board Fam Pract; 1989 Jul; 2(1):10-6. PubMed ID: 2635873
    [Abstract] [Full Text] [Related]

  • 36. Alprazolam in the treatment of panic disorders.
    Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A, Davies SR, Goetz D, Klein DF.
    J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
    [Abstract] [Full Text] [Related]

  • 37. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
    Pecknold JC, Swinson RP.
    Psychopharmacol Bull; 1986 Feb; 22(1):173-6. PubMed ID: 3726063
    [No Abstract] [Full Text] [Related]

  • 38. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D.
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [Abstract] [Full Text] [Related]

  • 39. Is buspirone effective for panic disorder?
    Sheehan DV, Raj AB, Sheehan KH, Soto S.
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [Abstract] [Full Text] [Related]

  • 40. The structure of phobias in panic disorder.
    Argyle N, Solyom C, Solyom L.
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.